Skip to content

The effect of Flexiban on knee osteoarthritis

The effect of Flexiban on knee osteoarthritis

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20251109067932N1
Enrollment
60
Registered
2025-11-26
Start date
2025-12-22
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee osteoarthritis. Osteoarthritis of knee

Interventions

Intervention 1: Intervention group: Patients in the intervention group will receive 2 Flexiban capsules twice a day for 2 months. Intervention 2: Control group: patients in the control group will rece

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to No maximum

Inclusion criteria

Inclusion criteria: Having written informed consent to participate in the study Age over 40 years Definitive diagnosis of lower limb osteoarthritis (knee) based on clinical and radiological criteria Patients with pain intensity of at least 4 on the VAS scale

Exclusion criteria

Exclusion criteria: History of taking immunosuppressive drugs one month prior to the start of the study Inflammatory diseases, rheumatoid arthritis, fibromyalgia, chronic low back pain, severe cardiovascular disease, active infections, and diabetic neuropathy Spinal or pelvic deformity Serious injury or surgery within the previous year on the lower limb History of fracture in the lower limb (knee) within at least the past six months Specific disease in the lower extremities History of steroid injection within the past 3 months

Design outcomes

Primary

MeasureTime frame
Pain intensity based on the WOMAC index. Timepoint: Pain intensity based on the WOMAC index at the beginning of the study (before the intervention) and 2 months after the intervention. Method of measurement: Based on the WOMAC questionnaire.;Quality of life based on the WOMAC index at the beginning of the study (before the intervention) and 2 months after the intervention. Timepoint: Quality of life based on the WOMAC index at the beginning of the study (before the intervention) and 2 months after the intervention. Method of measurement: Based on the WOMAC questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahbobeh Babaei

Shahid Beheshti University of Medical Sciences

mbabai19888@gmail.om+98 21 8857 7653

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026